How much does each dose of Doxorubicin cost? Analysis of market selling price and medical insurance reimbursement situation

Doxorubicin (Doxorubicin) is a commonly used anthracycline chemotherapy drug, widely used in the treatment of breast cancer, leukemia, lymphoma and other solid tumors. Domestically, doxorubicin has been officially launched and has been included in Category A of medical insurance, which means that patients can enjoy a certain percentage of cost reductions and reduce their financial burden if they meet the conditions for medical insurance reimbursement.

In the domestic market, doxorubicin has two common specifications: 5ml:10mg and 10ml:20mg. Among them, the latest market price of 5ml:10mg is between 900 and 1000. , and the selling price of 10ml:20mg fluctuates greatly, ranging from 2600 to 5000 yuan. Price differences are mainly affected by manufacturers, hospital procurement channels and regional drug price adjustment policies. Patients should consult the local hospital pharmacy for the latest price and medical insurance reimbursement ratio before use.

In overseas markets, the price of doxorubicin is relatively high. Taking the United States as an example, the average price of the 10mg specification is about 385USD, while the 25mg specification can be sold for 1057USD. This also reflects the obvious differences between international drug pricing and domestic policies. At the same time, overseas markets have not yet been uniformly included in the medical insurance or social security system, so patients' out-of-pocket costs are higher.

Overall, doxorubicin is available in the domestic market and enjoys medical insurance reimbursement policies, making treatment costs relatively controllable for patients. However, since chemotherapy usually requires multiple doses of medication, the cumulative cost is still considerable. Therefore, patients and their families should reasonably plan their treatment budget based on medical insurance policies, hospital purchase prices, and medication regimens. At the same time, they should select appropriate specifications and dosages under the guidance of doctors to balance efficacy and economic burden.

Reference link:https://www.drugs.com